{
  "id": "515c4f05298dcd4e51000006",
  "type": "list",
  "question": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?",
  "ideal_answer": "\u03b2-myosin heavy chain, alpha-myosin heavy chain, SR(Ca)ATPase, phospholamban, nucleotide-gated potassium channel 2, KCNE1, HCN2, HCN4, KCND2, KCND3, KCNA4",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/19171649",
    "http://www.ncbi.nlm.nih.gov/pubmed/15808842",
    "http://www.ncbi.nlm.nih.gov/pubmed/15831522",
    "http://www.ncbi.nlm.nih.gov/pubmed/23532677",
    "http://www.ncbi.nlm.nih.gov/pubmed/19629520",
    "http://www.ncbi.nlm.nih.gov/pubmed/11577024",
    "http://www.ncbi.nlm.nih.gov/pubmed/18622044",
    "http://www.ncbi.nlm.nih.gov/pubmed/20228172",
    "http://www.ncbi.nlm.nih.gov/pubmed/19832729",
    "http://www.ncbi.nlm.nih.gov/pubmed/17317766",
    "http://www.ncbi.nlm.nih.gov/pubmed/16155104",
    "http://www.ncbi.nlm.nih.gov/pubmed/15687816",
    "http://www.ncbi.nlm.nih.gov/pubmed/14704232"
  ],
  "snippets": [
    {
      "text": "A group of mice was treated with debutyl-dronedarone (DBD), a selective TR\u03b11 inhibitor (AMI-DBD)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23532677",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Furthermore, AMI resulted in \u03b2-myosin heavy chain overexpression and reduction in the ratio of SR(Ca)ATPase to phospholamban (PLB). The latter further declined in AMI-DBD mainly due to increased expression of PLB",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23532677",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "We identified that mice expressing the mutant TRalpha1R384C (TRalpha1+m mice) displayed a mild bradycardia, which becomes more pronounced during night activity or on stress and is accompanied by a reduced expression of nucleotide-gated potassium channel 2 mRNA in the heart",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20228172",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "KCNE1 was four to 10-fold overexpressed in mice deficient in TRalpha1",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19832729",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The bradycardia and prolonged QT(end) time in hypothyroid states can be explained by altered K(+) channel function due to decreased TRalpha1-dependent repression of KCNE1 expression",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19832729",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Consistently, TR alpha 1-infected myocytes exhibited larger I(f) current densities along with increased HCN2 and HCN4 mRNA and protein levels.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19629520",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "T3 stimulation enhanced KCND2 and KCND3 expression and decreased KCNA4 transcription, while KCNIP2 remained unaffected.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19171649",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "TRalpha1 increased I(to), while TRbeta1 significantly reduced I(to) in size, which was associated with TRalpha1-mediated increase and TRbeta1-mediated reduction of KCND2/3 transcription.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19171649",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "While the TRalpha1 aporeceptor enhanced KCND3 transcription, the TRbeta1 aporeceptor suppressed KCND3 expression, with both effects exhibiting ligand-dependent amplification upon T3 stimulation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19171649",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "PE, in the absence of T3, resulted in 5.0 fold increase in TRalpha1 expression in nucleus and 2.0 fold decrease in TRalpha1 expression in cytosol, P<0.05. As a result, a fetal pattern of myosin isoform expression with marked expression of beta-MHC was observed in PE treated vs the untreated cells, P<0.05.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18622044",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "PKC alpha overexpression in cardiomyocytes caused marked repression of triiodothyronine (T3)-responsive genes, alpha-myosin heavy chain, and the sarcoplasmic reticulum calcium-activated adenosinetriphosphatase SERCA2. Treatment with T3 for 4 h resulted in significant reductions of PKC alpha in nuclear and cytosolic compartments, and decreased TR alpha1 mRNA and protein, with normalization of phenotype.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16155104",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The mechanism of TH and TRalpha1-specific hypertrophy is novel for a nuclear hormone receptor and involves the transforming growth factor beta-activated kinase (TAK1) and p38",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15831522",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Excised TRalpha(1)+/m hearts showed an increased expression of phospholamban (PLB)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15808842",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "administration of dronedarone, an amiodarone-like compound that has been shown to preferentially antagonize thyroid hormone binding to thyroid hormone receptor alpha1 (TRalpha1),",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15687816",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "lpha-Myosin heavy chain (alpha-MHC) decreased in DRON while beta-myosin heavy chain (beta-MHC) and sarcoplasmic reticulum Ca2+ adenosine triphosphatase (ATPase) expression (SERCA) was similar to CONT.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15687816",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The activity of TR DNA binding to the transcriptional regulatory region in the alpha-MHC and SR Ca(2+)-ATPase genes and the mRNA and protein expression of alpha-MHC and SR Ca(2+)-ATPase in the heart and plasma 3,3'-triiodothyronine and thyroxine levels were altered in association with changes in the myocardial TR protein levels.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14704232",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "addition, TR cotransfection and treatment with the TRbeta1-selective agonist GC-1 suggested different functional coupling of the TR isoforms, TRbeta1 to transcription of beta-MyHC, SERCA, and TRbeta1, and TRalpha1 to alpha-MyHC transcription and increased myocyte size",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11577024",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "OBJECTIVE: The reduced heart rate and prolonged QT(end) duration in mice deficient in thyroid hormone receptor (TR) alpha1 may involve aberrant expression of the K(+) channel alpha-subunit KCNQ1 and its regulatory beta-subunit KCNE1.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19832729",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011988",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0046966",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0010861",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D037021",
    "http://www.uniprot.org/uniprot/THA_PYGAD",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0004887",
    "http://www.uniprot.org/uniprot/THA_NECMA",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013963",
    "http://www.uniprot.org/uniprot/THAA_XENLA",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006321",
    "http://www.uniprot.org/uniprot/THA_LITCT"
  ],
  "exact_answer": "\u03b2-myosin heavy chain, alpha-myosin heavy chain, SR(Ca)ATPase, phospholamban, nucleotide-gated potassium channel 2, KCNE1, HCN2, HCN4, KCND2, KCND3, KCNA4"
}